Human Vaccines & Immunotherapeutics, Volume 9, Issue 1 (2013)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Human Vaccines & Immunotherapeutics, Volume 9, Issue 1 (2013)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Volume 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs

Editor's Corner

Editorial
Letter from the Editor
Ronald W. Ellis & Eva M. Riedmann
Pages: 1-2
Published online: 01 Jan 2013
CitationforLetter from the Editor | PDF (85.2 KB)
  • 170 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Human Vaccines & Immunotherapeutics awards Top Reviewer of the Year
Ronald W. Ellis & Eva M. Riedmann
Pages: 3-6
Published online: 01 Jan 2013
First Page PreviewforHuman Vaccines & Immunotherapeutics awards Top Reviewer of the Year | PDF (215.8 KB)
  • 340 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

News, Policy & Profiles

News
Human Vaccines and Immunotherapeutics: News
Eva M. Riedmann
Pages: 7-10
Published online: 01 Jan 2013
AbstractforHuman Vaccines and Immunotherapeutics: News | PDF (95.7 KB)
  • 297 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
News
Profile: immatics biotechnologies GmbH
Paul Higham
Pages: 11-12
Published online: 01 Jan 2013
CitationforProfile: immatics biotechnologies GmbH | PDF (217.4 KB)
  • 322 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Nicotine vaccines to treat tobacco dependence
Maciej L. Goniewicz & Marcin Delijewski
Pages: 13-25
Published online: 29 Oct 2012
AbstractforNicotine vaccines to treat tobacco dependence | Full Text | References | PDF (960.9 KB)
  • 1853 Views
  • 31 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Plant-derived virus-like particles as vaccines
Qiang Chen & Huafang Lai
Pages: 26-49
Published online: 20 Sep 2012
AbstractforPlant-derived virus-like particles as vaccines | Full Text | References | PDF (978.8 KB)
  • 6661 Views
  • 117 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults
A phase I clinical trial
Rosalind Rowland, Ansar A. Pathan, Iman Satti, Ian D. Poulton, Magali M. L. Matsumiya, Megan Whittaker, Angela M. Minassian, Geraldine A. O’Hara, Matthew Hamill, Janet T. Scott, Stephanie A. Harris, Hazel C. Poyntz, Cynthia Bateman, Joel Meyer, Nicola Williams, Sarah C. Gilbert, Alison M. Lawrie, Adrian V.S. Hill & Helen McShane
Pages: 50-62
Published online: 10 Nov 2012
AbstractforSafety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults | Full Text | References | PDF (1 MB) | Supplemental
  • 1124 Views
  • 19 CrossRef citations
  • 0Altmetric
Open Access
Article
Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B
Ke Jin, Shixia Wang, Chunhua Zhang, Yanling Xiao, Shan Lu & Zuhu Huang
Pages: 63-73
Published online: 10 Nov 2012
AbstractforProtective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B | Full Text | References | PDF (3.8 MB)
  • 825 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Article
Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010
Petra Stöcker, Manuel Dehnert, Melanie Schuster, Ole Wichmann & Yvonne Deleré
Pages: 74-82
Published online: 20 Sep 2012
AbstractforHuman papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010 | Full Text | References | PDF (656.1 KB)
  • 1785 Views
  • 31 CrossRef citations
  • 0Altmetric
Free Access
Article
Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice
Liu Hongli, Li Xukui, Lei Ting, Li Wensheng, Si Lusheng & Zheng Jin
Pages: 83-89
Published online: 29 Oct 2012
AbstractforTransgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice | Full Text | References | PDF (1.3 MB)
  • 834 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access
Article
Assessing the burden of HPV-related cancers in Appalachia
Paul L. Reiter, James L. Fisher, Alana G. Hudson, Thomas C. Tucker, Jesse J. Plascak & Electra D. Paskett
Pages: 90-96
Published online: 10 Nov 2012
AbstractforAssessing the burden of HPV-related cancers in Appalachia | Full Text | References | PDF (1.3 MB)
  • 1212 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Human papilloma virus vaccines
Need to be introduced in India
Ramesh Verma & Pardeep Khanna
Pages: 97-99
Published online: 29 Oct 2012
AbstractforHuman papilloma virus vaccines | Full Text | References | PDF (576.1 KB)
  • 641 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Brief Report
Trust and the demand for autonomy may explain the low rates of immunizations among nurses
Orna Baron-Epel, Batya Madjar, Rami Grefat & Shmuel Rishpon
Pages: 100-107
Published online: 29 Oct 2012
AbstractforTrust and the demand for autonomy may explain the low rates of immunizations among nurses | Full Text | References | PDF (681.2 KB)
  • 1120 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Vaccine research, adolescents and Africa
Amber Abrams & Tamara Kredo
Pages: 108-111
Published online: 29 Oct 2012
First Page PreviewforVaccine research, adolescents and Africa | Full Text | References | PDF (887.8 KB)
  • 487 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
National Immunization Program in Iran
Whys and why nots
Maziar Moradi-Lakeh & Abdoulreza Esteghamati
Pages: 112-114
Published online: 01 Jan 2013
AbstractforNational Immunization Program in Iran | Full Text | References | PDF (143.7 KB)
  • 2399 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age
Isabel Leroux-Roels & Françoise Weber
Pages: 115-121
Published online: 01 Jan 2013
AbstractforIntanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age | Full Text | References | PDF (318 KB)
  • 1421 Views
  • 28 CrossRef citations
  • 0Altmetric
Open Access

Short Report

Brief Report
A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac®) in India
Prasad S. Kulkarni, Sidram K. Raut & Rajeev M. Dhere
Pages: 122-124
Published online: 01 Jan 2013
AbstractforA post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac®) in India | Full Text | References | PDF (599.4 KB)
  • 1038 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Brief Report
Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India
Babasaheb V. Tandale, Shailesh D. Pawar, Yogesh K. Gurav, Saurabh S. Parkhi & Akhilesh C. Mishra
Pages: 125-127
Published online: 09 Oct 2012
AbstractforAntibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India | Full Text | References | PDF (642.5 KB)
  • 436 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Additive preventive effect of influenza and pneumococcal vaccines in the elderly
Results of a large cohort study
Aba Mahamat, Jean-Pierre Daurès & Benoît de Wazières
Pages: 128-135
Published online: 01 Jan 2013
AbstractforAdditive preventive effect of influenza and pneumococcal vaccines in the elderly | Full Text | References | PDF (1 MB)
  • 1156 Views
  • 32 CrossRef citations
  • 0Altmetric
Free Access
Article
Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine
Results of a randomized trial
David W. Scheifele, Marc Dionne, Brian J. Ward, Curtis Cooper, Otto G. Vanderkooi, Yan Li, Scott A. Halperin & PHAC/CIHR Influenza Research Network
Pages: 136-143
Published online: 01 Jan 2013
AbstractforSafety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine | Full Text | References | PDF (291.7 KB)
  • 677 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly
A matched case-control study
Roberto Gasparini, Daniela Amicizia, Piero Luigi Lai, Stefania Rossi & Donatella Panatto
Pages: 144-152
Published online: 10 Nov 2012
AbstractforEffectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly | Full Text | References | PDF (853.6 KB)
  • 1902 Views
  • 39 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Mini-chaperones
Potential immuno-stimulators in vaccine design
Azam Bolhassani & Sima Rafati
Pages: 153-161
Published online: 29 Oct 2012
AbstractforMini-chaperones | Full Text | References | PDF (1.1 MB)
  • 1018 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Review Article
The changing epidemiology of meningococcal disease in North America 1945–2010
Carmen Baccarini, Andrew Ternouth, Heather Wieffer & Andrew Vyse
Pages: 162-171
Published online: 29 Oct 2012
AbstractforThe changing epidemiology of meningococcal disease in North America 1945–2010 | Full Text | References | PDF (1.1 MB)
  • 1074 Views
  • 46 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants
M.R. Lokeshwar, Sheila Bhave, Ashok Gupta, V.K. Goyal & Anuj Walia
Pages: 172-176
Published online: 01 Jan 2013
AbstractforImmunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants | Full Text | References | PDF (500 KB)
  • 909 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
Safety of post-exposure rabies prophylaxis during pregnancy: A follow-up study from Guangzhou, China
Guihua Huang, Huazhang Liu, Qing Cao, Beiyan Liu, Huai Pan & Chuanxi Fu
Pages: 177-183
Published online: 01 Jan 2013
AbstractforSafety of post-exposure rabies prophylaxis during pregnancy: A follow-up study from Guangzhou, China | PDF (672.1 KB)
  • 783 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access
Article
Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV
Silvio Tafuri, Domenico Martinelli, Rosa Prato & Cinzia Germinario
Pages: 184-188
Published online: 29 Oct 2012
AbstractforVaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV | PDF (678.3 KB)
  • 335 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Article
Environmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009–2010
Amy Parker Fiebelkorn, Jennifer B. Rosen, Cedric Brown, Christopher M. Zimmerman, Hyman Renshowitz, Christopher D'Andrea, Kathleen M. Gallagher, Rafael Harpaz & Jane R. Zucker
Pages: 189-194
Published online: 01 Jan 2013
AbstractforEnvironmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009–2010 | PDF (626.5 KB)
  • 378 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access

Letter

Letter
Challenges associated with the recent outbreaks of wild-type Poliovirus in previously polio-free countries
Subhash C. Arya & Nirmala Agarwal
Pages: 195-196
Published online: 30 Oct 2012
CitationforChallenges associated with the recent outbreaks of wild-type Poliovirus in previously polio-free countries | PDF (85.8 KB)
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Letter
Horizontal transmission of live vaccines
Prasad S Kulkarni, suresh Jadhav & rajeev dhere
Page: 197
Published online: 01 Jan 2013
CitationforHorizontal transmission of live vaccines | PDF (521.6 KB)
  • 334 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro
Petr Lokhov & Elena E. Balashova
Pages: 198-209
Published online: 01 Jan 2013
AbstractforTumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro | PDF (2.5 MB)
  • 318 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Commentary

Peptide vaccines for hepatocellular carcinoma
Daisuke Nobuoka, Toshiaki Yoshikawa, Yu Sawada, Toshiyoshi Fujiwara & Tetsuya Nakatsura
Pages: 210-212
Published online: 01 Jan 2013
AbstractforPeptide vaccines for hepatocellular carcinoma | Full Text | References | PDF (786.1 KB)
  • 1309 Views
  • 25 CrossRef citations
  • 0Altmetric
Open Access
Cancer targeting vaccines:  Surrogate measures of activity
John Nemunaitis
Pages: 213-218
Published online: 01 Jan 2013
AbstractforCancer targeting vaccines:  Surrogate measures of activity | PDF (964.4 KB)
  • 220 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Therapeutic vaccines
The ultimate personalized therapy?
James L. Gulley
Pages: 219-221
Published online: 20 Sep 2012
AbstractforTherapeutic vaccines | Full Text | References | PDF (642 KB)
  • 1161 Views
  • 39 CrossRef citations
  • 0Altmetric
Free Access
How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
Xin Tian, Motao Zhu & Guangjun Nie
Pages: 222-225
Published online: 29 Oct 2012
AbstractforHow can nanotechnology help membrane vesicle-based cancer immunotherapy development? | Full Text | References | PDF (739.4 KB)
  • 1506 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Use of narratives to enhance childhood vaccine acceptance: Results of an online experiment among Canadian parents
Eve Dube et al.
Article | Published online: 24 Jul 2024
Open Access
Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy
Yue Ma et al.
Article | Published online: 23 Jul 2024
Open Access
Vaccine approaches to treat urothelial cancer
Giulia Claire Giudice et al.
Review Article | Published online: 23 Jul 2024
Open Access
CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy
Yasemin Ahrberg et al.
Meeting Report | Published online: 23 Jul 2024
Open Access